Results of observational study to determine K-ras mutation rates in 2458 patients with metastatic colorectal cancer in Turkey (TURKRAS Study).

Gumus, MahmutDane, FaysalKarabulut, BulentUygun, KazimAydin, KubraOrhan, BulentOksuzoglu, Berna2024-04-242024-04-2420150732-183X1527-7755https://doi.org/10.1200/jco.2015.33.15_suppl.e14516https://hdl.handle.net/11468/18291Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer -- MAY 29-JUN 02, 2015 -- Chicago, IL[Abstract Not Available]eninfo:eu-repo/semantics/closedAccess[No Keyword]Results of observational study to determine K-ras mutation rates in 2458 patients with metastatic colorectal cancer in Turkey (TURKRAS Study).Results of observational study to determine K-ras mutation rates in 2458 patients with metastatic colorectal cancer in Turkey (TURKRAS Study).Conference Object3315WOS:00035803690264110.1200/jco.2015.33.15_suppl.e14516Q1